Curcumin: A Golden Remedy for Joint Health New Formulations dramatically enhance this ancient botanical’s bioavailability
Liquid gold. Golden milk. That brilliant saffron-hued spice. We hear a lot about turmeric these days—also known as Curcuma longa—a member of the ginger family, and native of Southeast Asia.[i] Valued for its brilliant hue and distinctive spicy-bitter flavor, its use as a dye, a spice, and in religious ceremonies dates back nearly 4000 years.[ii],[iii] Turmeric is a mainstay in Ayurvedic and Chinese medicine, thanks in large part to curcuminoids—three bright golden-colored, lipophilic polyphenols (curcumin, demethoxycurcumin and bisdemethoxycurcumin), collectively known as “curcumin” that are derived from the plant’s rhizomes.[iv],[v] The main component of the root is a volatile oil containing turmerone.
Curcumin was first isolated almost 200 years ago.[vi] Curcuminoids, the phenolic compounds responsible for its color, make up 2-5% of turmeric, and exhibit antioxidant, anti-inflammatory, antiviral, antibacterial, and antifungal activity.[vii] In particular, curcuminoids have antioxidant and anti-inflammatory properties that may be useful in lessening the pain and inflammation of arthritis.[viii] Several studies have been conducted which have confirmed the anti-arthritic effects of curcumin in humans with both osteoarthritis and rheumatoid arthritis.[ix],[x]
Anti-Inflammatory Properties of Curcumin
Curcumin is well recognized for its capacity to regulate and boost the activity of anti-inflammatory molecules in the body.[xi],[xii] It can function as a potent antioxidant, proving helpful in a variety of conditions, such as diabetes, osteoarthritis, rheumatoid arthritis, cardiovascular conditions and degenerative diseases.[xiii],[xiv],[xv] It increases activity of two of the body’s potent antioxidants, superoxide dismutase (SOD) and catalase.[xvi],[xvii] Curcumin is also a fat-loving, or lipophilic compound, and thus like vitamin E is an efficient scavenger of lipid peroxyl radicals.[xviii],[xix] ,[xx],[xxi],[xxii]
Curcumin can trigger the expression and production of interleukin 10 (IL-10), a powerful cytokine with potent inflammation regulating activity.[xxiii] IL-10 is a key factor in controlling a variety of inflammatory conditions, including osteoarthritis and rheumatoid arthritis, and has been described by some researchers as a “master switch” that can turn off inflammatory activity in the body.[xxiv] Curcumin’s demonstrated ability to boost IL-10 production suggests the usefulness of this golden remedy in alleviating inflammation affecting a variety of chronic conditions, as well as modulating the immune response.[xxv] For this reason, it is not surprising that several studies have been conducted which have confirmed the anti-arthritic effects of curcumin in humans with both rheumatoid and osteoarthritis.[xxvi],[xxvii]
Curcumin and Arthritis
Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune, inflammatory joint disease, which may cause damage to bone and cartilage, producing pain, limited mobility, and in some cases, frank physical disability.[xxviii] In one randomized, double-blind, placebo-controlled study, a bioavailable form of curcumin alleviated clinical symptoms associated with RA. Thirty-six patients with active RA were divided into three groups of twelve: one group was given a placebo twice daily, one received curcumin at a dosage of 250 mg twice daily (low-dose), and the third group received 500 mg twice daily (high-dose). By the end of the 90-day study, individuals who received both the low and high dose of the bioavailable curcumin experienced significant improvement in tests measuring clinical symptoms, while none of the patients who received the placebo had significant improvement. These findings suggest that curcumin has both analgesic and anti-inflammatory activities useful for the management of RA, starting at dosages as low as 250mg twice daily. All of the study participants tolerated the curcumin product well and reported no negative side effects.[xxix]
Curcumin has also demonstrated usefulness in the management of osteoarthritis (OA), a chronic joint condition that affects over 250 million people worldwide and is marked by inflammation, including elevated inflammatory cytokine levels.[xxx],[xxxi] In a randomized, double-blind, placebo-controlled trial, 40 participants suffering from mild-to-moderate OA in the knee were given either 1500 mg of highly bioavailable curcuminoids daily in three divided doses, or a matched placebo, for six weeks. Clinical symptoms were measured using the visual analog scale (VAS) which measures intensity of symptoms, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale, and Lequesne’s pain functional index (LPFI) scale. At the conclusion of the study, participants who received the curcuminoids achieved significantly lower scores on all three scales compared with the placebo group.[xxxii]
In a longer randomized control trial conducted over eight months, 50 patients with OA received either standard treatment as prescribed by their physician, or standard treatment plus the addition of two 500-mg tablets of a natural curcuminoid formula. Scores on the WOMAC, physical function, and stiffness scales decreased significantly in the group receiving the curcuminoid compound in comparison with the control group. In addition, the group given the curcuminoid compound also exhibited significant decreases in all inflammatory markers.[xxxiii]
Potent Effects on Muscle Pain
Joint and muscle pain often go hand in hand, and curcumin also shows promise in reducing the inflammation and sore muscles resulting from intense exercise.
A highly bioavailable curcumin formula had measurable impact on muscle damage and recovery in 59 healthy, physically active, young adult participants after downhill running. This eight-week study measured levels of creatine kinase—which are elevated when there is muscle damage. Each participant also self-reported muscle soreness on a numerical scale. The participants were divided into three groups: one being given 50 mg of bioavailable curcuminoids, another given 200 mg of bioavailable curcuminoids, and a third given the placebo. Measurements were taken before the exercise session, immediately following the session, and again at one, 24, 48, and 72 hours post-session. Both curcumin groups had significantly reduced elevation in creatine kinase levels in comparison with the placebo group. In the group that received 200 mg of curcumin, self-reported pain scores were significantly reduced as well.[xxxiv]
In a double-blind, randomized, placebo-controlled follow-up study, the impact of the bioavailable curcumin on muscle damage and recovery following a session of running downhill was assessed. Sixty-two men and women were randomly selected to again receive either 50 mg curcuminoids, 200 mg curcuminoids, or a placebo for a period of eight weeks. At the end of the supplementation period, participants completed an exercise session of downhill running. Muscle function, and isokinetic peak flexion and extension were assessed just before the exercise session, and again at one, 24, 48, and 72 hours post-session. In this study, the high dose of bioavailable curcuminoids were observed to attenuate performance decrements following the downhill running, eccentric loading situation, suggesting it may lead to improvements in training if used on an ongoing basis.[xxxv]
Curcumin and Bioavailability
Curcumin’s array of impressive health benefits is limited by the naturally poor bioavailability of curcuminoids, due to a low absorption rate, rapid metabolism, and quick elimination from the body.[xxxvi] In almost all of the studies cited in which curcumin successfully achieved a host of benefits, the formulations used were such that the natural bioavailability of the compound was enhanced by the addition of other agents.[xxxvii],[xxxviii],[xxxix],[xl]
A newly formulated curcumin compound shows greater uptake and bioavailability than standard curcumin, as well as many of the enhanced bioavailability formats currently available. A randomized, double-blind, crossover study on twelve healthy adult volunteers compared increases in levels of beneficial curcuminoids following oral ingestion of four curcumin formulations—the new highly bioavailable formulation, denoted as CHC, a standardized curcumin mixture (CS), and a curcumin phytosome formulation (CP), and a formulation with volatile oils of turmeric rhizome (CTR).
Bioavailability was enhanced in the CHC formulation by dissolving a highly purified powder consisting of at least 95% curcuminoids in a water-soluble base, along with other encapsulating agents. Antioxidants in the form of tocopherol and ascorbyl palmitate were added to protect the curcumin from degradation.
Study participants were given 376 mg of curcumin either as CP, CTR, or CHC, or 1,800 mg of non-enhanced standard CS.[xli] All participants tolerated the formulations well. CHC significantly increased the quantity of curcuminoids in the bloodstream compared to CS, CP and CTR. In fact, the CHC formulation showed a 45.9-fold increase in oral absorption in comparison to the CS formulation, a 34.9-fold increase over the volatile oil CTR format, and a 5.8-fold increase over the phytosome format. The CHC formulation also increased curcuminoids in the blood in comparison to the other formulations; it demonstrated an impressive 136.3-fold improved curcumin appearance in blood in comparison to unformulated standard curcumin. These findings indicate that the formulation consisting of 95% curcuminoids, combined with a water-soluble carrier, cellulosic derivatives, and natural antioxidants markedly augments the presence of beneficial curcuminoids in the bloodstream after oral ingestion when compared to unformulated standard curcumin, as well as traditional bioavailability-enhanced products. [xlii]
Curcumin’s popularity and reputation as a golden botanical continues to increase as studies confirm its traditionally acclaimed properties and health benefits, and we find means to dramatically enhance its bioavailability.
[i] Priyadarsini, KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014. 19 (12): 20091–112. PMID 25470276.
[ii] Prasad S, Aggarwall BB. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition.: CRC Press/Taylor & Francis; 2011. Chapter 13. PMID: 22593922
[iii] Tayyem RF, Heath DD, Al-Delaimy WK, et al. Curcumin content of turmeric and curry powders. Nutr Cancer. 2006;55(2):126-31. PMID 17044766
[iv] Nelson, KM, Dahlin, JL, Bisson, J, et al. The Essential Medicinal Chemistry of Curcumin: Miniperspective. Journal of Medicinal Chemistry. 2017. 60 (5): 1620–1637. PMID 28074653.
[v] Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017 Sep 2;57(13):2889-2895. PMID 26528921
[vi] Aggarwal BB, Sundaram C, Malani N, et al. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007; 595:1-75. PMID 17569205
[vii] Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009 Jan;41(1):40-59. PMID 18662800
[viii] Amalraj A, Pius A, Gopi S, et al. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A review. J Tradit Complement Med. 2016 Jun 15;7(2):205-233. PMID 28417091
[ix] Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016 Aug 1; 19(8): 717–729. PMCID: PMC5003001
[x] Henrotin Y, Priem F, Mobasheri, A. Curcumin: A new paradigm and therapeutic opportunity for the treatment of osteoarthritis: Curcumin for osteoarthritis management. SpringerPlus 2013, 2, 56. PMID 23487030
[xi] Boonjaraspinyo S, Boonmars, T, Aromdee C, et al. Turmeric reduces inflammatory cells in hamster opisthorchiasis. Parasitol. Res. 2009, 105,1459–1463. PMID 19633869
[xii] Sriraj P, Boonmars T, Boonjaraspinyo S, et al. Effect of curcumin on pathogenesis of hamster-opisthorchiasis through apoptosis-related gene expression. Southeast Asian J Trop Med Public Health. 2009 Nov;40(6):1208-15. PMID 20578454
[xiii] Sahebkar, A. Serbanc, MC, Ursoniuc S, et al. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J. Funct. Foods 2015, 18, 898–909. PMID 26857863
[xiv] Wang XT, Gong Y, Zhou B, et al. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats. Biomed Pharmacother. 2017 Nov 16;97:1461-1467. PMID: 29156537
[xv] Di Pietro M, Filardo S, Falasca F, et al. Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.Int J Mol Sci. 2017 Nov 18;18(11). pii: E2459. Review. PMID: 29156574
[xvi] Xie Z, Wu B, Shen G. Curcumin alleviates liver oxidative stress in type 1 diabetic rats. Mol Med Rep. 2017 Oct 26. PMID 29115468
[xvii] Jaiswal SK, Gupta VK, Siddiqi NJ. Curcumin mediated attenuation of carbofuran induced toxicity in the heart of Wistar rats. Cell Mol Biol (Noisy-le-grand). 2017 Jul 31;63(6):12-17. PMID 28968202
[xviii] Slavova-Kazakova AK, Angelova SE, Veprintsev TL, et al. Antioxidant potential of curcumin-related compounds studied by chemiluminescence kinetics, chain-breaking efficiencies, scavenging activity (ORAC) and DFT calculations.Beilstein J Org Chem. 2015 Aug 11;11:1398-411. PMID: 26425195
[xix] Masuda T, Toi Y, Bando H, Maekawa T, et al. Structural identification of new curcumin dimers and their contribution to the antioxidant mechanism of curcumin. J Agric Food Chem. 2002 Apr 24;50(9):2524-30. PMID 11958616
[xx] Roginsky V. Chain-breaking antioxidant activity of natural polyphenols as determined during the chain oxidation of methyl linoleate in Triton X-100 micelles. Arch Biochem Biophys. 2003 Jun 15;414(2):261-70. PMID 12781778
[xxi] Priyadarsini KI, Maity DK, Naik, H, et al. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin.Free Radic. Biol. Med. 2003, 35, 475–484. PMID 12927597
[xxii] Niki E. Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med. 2014 Jan;66:3-12. PMID: 23557727
[xxiii] Ma X, Yan W, Zheng H et al. Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells [version 1; referees: 3 approved] F1000Research 2015, 4(F1000 Faculty Rev):1465 PMID 26918147
[xxiv] Oft M, IL-10: master switch from tumor-promoting inflammation to antitumor immunity. Cancer Immunol Res. 2014 Mar;2(3):194-9. PMID 24778315
[xxv] Mollazadeh H, Cicero AFG, Blesso CN, et al. (2017): Immune Modulation by Curcumin: The Role of Interleukin-10, Crit Rev Food Sci Nutr. 2017 Aug 11:1-13., PMID 28799796
[xxvi] Belcaro G, Hosoi M, Pellegrini L, et al. A controlled study of a lecithinized delivery system of curcumin (meriva®) to alleviate the adverse effects of cancer treatment. Phytother. Res. 2014, 28, 444–450. PMID 23775598
[xxvii] Henrotin Y, Priem F, Mobasheri, A. Curcumin: A new paradigm and therapeutic opportunity for the treatment of osteoarthritis: Curcumin for osteoarthritis management. SpringerPlus 2013, 2, 56. PMID 23487030
[xxviii] Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659–672. PMID 27156434
[xxix] Amalraj A1, Varma K1, Jacob J1J A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group StudyMed Food. 2017 Oct;20(10):1022-1030. doi: 10.1089/jmf.2017.3930. Epub 2017 Aug 29.
[xxx] Goldring, M.B. Osteoarthritis and cartilage: The role of cytokines. Curr. Rheumatol. Rep. 2000, 2, 459–465. PMID 11123098
[xxxi] Rahimnia AR, Panahi Y, Alishiri, A, et al. Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: Findings from a randomized double-blind placebo-controlled trial. Drug Res. 2015, 65, 521–525. PMID 25050518
[xxxii] Panahi Y, Rahimnia, AR, Sharafi M, et al. Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo-controlled trial. Phytother. Res. 2014, 28, 1625–1631. PMID 24853120
[xxxiii] Belcaro G, Cesarone MR, Dugall M, et al. Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med. 2010, 52, 55–62. PMID 20657536
[xxxiv] Jäger R, Caldwell AR, Sanders E, et al. Curcumin Reduces Muscle Damage and Soreness Following Muscle-Damaging Exercise. The FASEB Journal. 2017 Apr 1;31
[xxxv] Oliver JM, Caldwell A, Sanders, E, et al. Novel Form of Curcumin Attenuates Performance Decrements Following Muscle Damaging Exercise: Abstract. Available at: http://www.fasebj.org/content/31/1_Supplement/lb415.abstract?sid=0e6d039a-18a2-4237-9933-c96a9d1617ca
[xxxvi] Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4(6):807–818. PMID 17999464
[xxxvii] Li X, Uehara S, Sawangrat K. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement. Int J Pharm. 2017 Nov 18;535(1-2):340-349. PMID 29157961
[xxxviii] Tian C, Asghar S, Wu Y, et al. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers. Int J Nanomedicine. 2017 Oct 27;12:7897-7911. PMID: 29138557
[xxxix] Aqil F, Munagala R, Jeyabalan J, et al. Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin. AAPS J. 2017 Nov;19(6):1691-1702. PMID: 29047044
[xl] Jaisamut P, Wiwattanawongsa K, Graidist P, et al. Enhanced Oral Bioavailability of Curcumin Using a Supersaturatable Self-Microemulsifying System Incorporating a Hydrophilic Polymer; In Vitro and In Vivo Investigations. AAPS PharmSciTech. 2017 Oct 3. PMID: 28975598
[xli] Cuomo J, Appendino G, Dern AS, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 2011,74(4):664–669. PMID 21413691
[xlii] Jäger, et al. Comparative absorption of curcumin formulations. Nutrition Journal 2014 13:11. Jan 24;13:11. PMID: 24461029
4th - 8th Ocotber 2018
Applying Functional Medicine in Clinical Practice is a well-orchestrated, comprehensive, patient centered educational programme that helps you deepen your clinical understanding and practical application of the Functional Medicine Matrix ModelClick for further information
Curcumin: A Golden Remedy for Joint Health New Formulations dramatically enhance this ancient botanical’s bioavailabilityLiquid gold. Golden milk. That brilliant saffro...
- A Novel Galactofucan Sulfate Extract Enhances I...
- An Interview with Polymer Chemist Helen Fitton ...
- Join award-winning Educator, International Spea...
- As Functional Medicine practitioners, we’re awa...
Updates on your email
Don't miss out on our email updates